Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
In Vitro Experiment Suppliers In Europe
4 companies found
based inLyon, FRANCE
NOVA is a leading Healthtech company which simulates in silico clinical trials in virtual patient populations for bio-pharma companies with a need to accelerate and de-risk their R&D. With over a decade of experience and multiple commercial projects ...
based inSnailwell, UNITED KINGDOM
Tristel is a manufacturer of infection control, contamination control and hygiene products. It has four principal activities: Medical Instrument Disinfection under the Tristel brand. Hospital Surface Disinfection under the Cache brand. Cleanroom, ...
Daisygrip is the first hygienically reusable venous tourniquet and has a unique intuitive locking system. The simpler application and disinfection method ensure lasting safety and permanently reduce costs. With daisygrip, every routine blood sample ...
based inBudapest, HUNGARY
Femtonics is a prominent player in the field of in-vivo microscopy, focusing on providing advanced imaging solutions tailored for the neuroscientific community. The company's expertise lies in the development of two-photon laser scanning ...
based inWroclaw, POLAND
Pure Biologics is a biopharmaceutical company focused on the biological drug and non-systemic therapies discovery and development. We operate in the areas of immuno-oncology, autoimmunology, and rare neurological diseases, conducting research based ...
Colorectal cancer (CRC) is the second-most common cancer diagnosed in women and third-most in men. Based upon five-year survival rates, chances of becoming cured remain to be approximately 65%. Therapies targeting immunological checkpoints, or more ...